Working… Menu

Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02841150
Recruitment Status : Completed
First Posted : July 22, 2016
Last Update Posted : March 29, 2018
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 2016
Actual Study Completion Date : August 2016